NIM
PTX

Needham Investment Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Needham Investment Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,000
Closed -$214K – 127
2014
Q1 		$214K Buy
+4,000
New +$132K 0.05% 112

Other funds holding PTX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Needham Investment Management's PTX Position: Q2 2014 in Review

Needham Investment Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2014, closing a stake of 4,000 shares — an estimated $214K sold.

Needham Investment Management first reported a position in PTX in Q1 2014 and held it in 1 quarter. The position peaked at $214K in Q1 2014. 89 funds tracked by Wall St. Rank hold PTX as of Q2 2014.

  • Needham Investment Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2014 after selling out during the quarter.
  • Needham Investment Management sold 4,000 Pernix Therapeutics Holdings, Inc. shares in Q2 2014, an estimated $214K.
  • Needham Investment Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 1 quarter.
  • Needham Investment Management's Pernix Therapeutics Holdings, Inc. position peaked at $214K in Q1 2014.
  • 89 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2014.

Based on Needham Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.